CXCR1/2 Inhibitor SX-682: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 2 1

Condition	Trials
Advanced Lung Non-Small Cell Carcinoma	1
Lung cancer	1
Metastatic Lung Non-Small Cell Carcinoma	1
Recurrent Lung Non-Small Cell Carcinoma	1
Stage III Lung Cancer AJCC v8	1
Stage IV Lung Cancer AJCC v8	1

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
NCT07322341 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

1 recruiting trial across 6 conditions.

No. For the full record, search ClinicalTrials.gov.